NaughtyPines

THE WEEK AHEAD: KBH, DAL, ICLN, SLV, EWZ, KRE, XLE, IWM/RUT

AMEX:IWM   iShares Russell 2000 ETF
EARNINGS:

There aren't a ton of earnings next week. Some financials are announcing, but I generally don't play those a ton for volatility contraction, since they never really frisk up that much, and all are below 50% 30-day implied here. KBH provides the best bang for your buck with the implied metrics I'm generally looking for (>50%), followed by DAL. Both, however, are at the low end of their 52-week range, in part due to the massive vol spike we experienced in March, which will make that metric somewhat misleading here.

KBH (18/56/14.5%),* Tuesday after market close.
DAL (7/53/12.9%), Wednesday before market open.
C (17/44/9.8%), Friday before market open.
JPM (14/32/7.8%), Friday before market open.
WFC (22/44/10.6%), Friday before market open.


EXCHANGE-TRADED FUNDS RANKED BY PERCENTAGE THE FEBRUARY 19TH AT-THE-MONEY SHORT STRADDLE IS PAYING AS A FUNCTION OF STOCK PRICE:

ICLN (14/79/20.0%)
SLV (31/48/11.3%)
EWZ (16/44/10.6%)
XLE (22/41/10.2%)
KRE (17/42/9.9%)


BROAD MARKET:

Pictured here is an IWM short put out in March at the strike paying at least 1% of the strike in credit. An IRA trade, I would look to roll up intraexpiry to lock in realized gain with >45 days 'til expiry, take profit on approaching worthless (<.20), and sell call against if assigned. Currently 67 days 'til expiry, it is understandably a bit long in duration, but I already have some on in the February monthly.

IWM (26/34/7.6%)
QQQ (21/31/6.9%)
DIA (14/24/5.2%)
SPY (11/24/5.0%)
EFA (14/21/4.7%)

* -- The first metric is the implied volatility rank or percentile (i.e., where implied is relative to where it's been over the past 52 weeks); the second, the 30-day implied volatility ; and the third, what the at-the-money short straddle is paying as a function of the stock price.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.